Skip to content
10-Q

Quarterly Report

Regulus Therapeutics Inc.

0001628280-24-046316

← back to feed
Filed
Nov 7, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 1, 2024 65.5M sh
Shares Diluted Q3 2024 · Sep 30, 2024 65.47M sh
Shares Diluted Q3 2024 · Sep 30, 2024 53.27M sh
Shares Diluted Q3 2024 · Sep 30, 2023 19.63M sh
Shares Diluted Q3 2024 · Sep 30, 2023 18.54M sh
Capex Q3 2024 · Sep 30, 2024 $340K
Capex Q3 2024 · Sep 30, 2023 $542K
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$29.83M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$20.64M
Short Term Debt Q3 2024 · Sep 30, 2024 $0
Short Term Debt Q3 2024 · Dec 31, 2023 $1.33M
Short Term Investments Q3 2024 · Sep 30, 2024 $60.94M
Short Term Investments Q3 2024 · Dec 31, 2023 $0
Cash And Equivalents Q3 2024 · Sep 30, 2024 $26.37M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $23.77M
Cash And Equivalents Q3 2024 · Sep 30, 2023 $25.83M
Stockholders Equity Q3 2024 · Sep 30, 2024 $86.81M
Stockholders Equity Q3 2024 · Jun 30, 2024 $98.18M
Stockholders Equity Q3 2024 · Mar 31, 2024 $107.59M
Stockholders Equity Q3 2024 · Dec 31, 2023 $21.19M
Stockholders Equity Q3 2024 · Sep 30, 2023 $28.26M
Stockholders Equity Q3 2024 · Jun 30, 2023 $34M
Stockholders Equity Q3 2024 · Mar 31, 2023 $26.6M
Stockholders Equity Q3 2024 · Dec 31, 2022 $33.29M
Current Liabilities Q3 2024 · Sep 30, 2024 $6.48M
Current Liabilities Q3 2024 · Dec 31, 2023 $8.51M
Total Liabilities Q3 2024 · Sep 30, 2024 $6.96M
Total Liabilities Q3 2024 · Dec 31, 2023 $9.56M
Current Assets Q3 2024 · Sep 30, 2024 $91.69M
Current Assets Q3 2024 · Dec 31, 2023 $28.18M
Total Assets Q3 2024 · Sep 30, 2024 $93.76M
Total Assets Q3 2024 · Dec 31, 2023 $30.75M
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.21
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.63
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.40
Eps Diluted Q3 2024 · Sep 30, 2023 −$1.19
Eps Basic Q3 2024 · Sep 30, 2024 −$0.21
Eps Basic Q3 2024 · Sep 30, 2024 −$0.63
Eps Basic Q3 2024 · Sep 30, 2023 −$0.40
Eps Basic Q3 2024 · Sep 30, 2023 −$1.19
Sga Expense Q3 2024 · Sep 30, 2024 $3.86M
Sga Expense Q3 2024 · Sep 30, 2024 $10.6M
Sga Expense Q3 2024 · Sep 30, 2023 $2.64M
Sga Expense Q3 2024 · Sep 30, 2023 $7.42M
Rd Expense Q3 2024 · Sep 30, 2024 $11.35M
Rd Expense Q3 2024 · Sep 30, 2024 $25.7M
Rd Expense Q3 2024 · Sep 30, 2023 $5.49M
Rd Expense Q3 2024 · Sep 30, 2023 $15.39M
Net Income Q3 2024 · Sep 30, 2024 −$14.06M
Net Income Q3 2024 · Sep 30, 2024 −$33.57M
Net Income Q3 2024 · Jun 30, 2024 −$11.04M
Net Income Q3 2024 · Mar 31, 2024 −$8.47M
Net Income Q3 2024 · Sep 30, 2023 −$7.82M
Net Income Q3 2024 · Sep 30, 2023 −$21.98M
Net Income Q3 2024 · Jun 30, 2023 −$7.01M
Net Income Q3 2024 · Mar 31, 2023 −$7.14M
Operating Income Q3 2024 · Sep 30, 2024 −$15.21M
Operating Income Q3 2024 · Sep 30, 2024 −$36.29M
Operating Income Q3 2024 · Sep 30, 2023 −$8.13M
Operating Income Q3 2024 · Sep 30, 2023 −$22.81M